David M. Benedek, MD
- 3Articles
- 10.3KReads1
- 1998–2020Active
- 13Collaborators
- 18Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
David M. Benedek, MD, has published extensively on the pharmacologic treatment of psychiatric conditions including posttraumatic stress disorder, premenstrual dysphoric disorder, and schizoaffective disorders. His work includes clinical trials investigating glutamatergic modulators for antidepressant-resistant PTSD symptoms and the use of sertraline during the luteal phase for premenstrual dysphoric disorder. Benedek's research also addresses treatment strategies for patients hospitalized with schizoaffective disorder. His publications span from 1998 to 2020 in Psychiatrist.com journals.
Publications
Riluzole for Antidepressant-Resistant PTSD
October 27, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
